CN Patent

CN102793924B — 一种由二氧化硅和磷酸氢钙组成的药用预混剂

Assigned to Tianjin Hongri Aileyi Pharmaceutical Adjuvant Co ltd · Expires 2013-07-24 · 13y expired

What this patent protects

本发明公开了一种由二氧化硅和磷酸氢钙组成的药用预混剂，属于药物制剂技术领域，其特征在于，预混剂的成分为二氧化硅和磷酸氢钙，二者的重量份数比例为二氧化硅∶磷酸氢钙=0.1%～5.0%∶99.9%～95.0%，其混合方法是物理混合。

USPTO Abstract

本发明公开了一种由二氧化硅和磷酸氢钙组成的药用预混剂，属于药物制剂技术领域，其特征在于，预混剂的成分为二氧化硅和磷酸氢钙，二者的重量份数比例为二氧化硅∶磷酸氢钙=0.1%～5.0%∶99.9%～95.0%，其混合方法是物理混合。

Drugs covered by this patent

Patent Metadata

Patent number
CN102793924B
Jurisdiction
CN
Classification
—
Expires
2013-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Hongri Aileyi Pharmaceutical Adjuvant Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.